This inventor holds 3 USPTO granted patents. Top assignees: Societe De Conseils De Recherches Et D'applications Scientifiques Sas, Biomeasure Incorporated. Active years: 2001-2007.
Company Filing History:
2 out of 47 
1 out of 52 
Years Active: 2001-2007
Title: The Innovations of Philip G. Kasprzyk
Introduction
Philip G. Kasprzyk is an accomplished inventor based in Boston, MA (US). He has made significant contributions to the field of medical science, particularly in the area of fibrosis treatment. With a total of 3 patents to his name, his work has the potential to impact patient care positively.
Latest Patents
Among his latest patents is a method of inhibiting fibrosis with a somatostatin agonist. This invention relates to a method of inhibiting fibrosis in a patient by administering a therapeutically effective amount of a somatostatin, a somatostatin agonist, or a pharmaceutically acceptable salt thereof. This innovative approach aims to provide a new avenue for treating patients suffering from fibrosis.
Career Highlights
Throughout his career, Philip has worked with notable companies such as Société de Conseils de Recherches et d'Applications Scientifiques SAS and Biomeasure Incorporated. His experience in these organizations has contributed to his expertise and success as an inventor.
Collaborations
Philip has collaborated with various professionals in his field, including his coworker Michael DeWitt Culler. These partnerships have likely enhanced his research and development efforts.
Conclusion
Philip G. Kasprzyk's contributions to the field of medical science through his innovative patents demonstrate his commitment to improving patient outcomes. His work in inhibiting fibrosis showcases the potential of targeted therapies in modern medicine.